Logo image of ABLD.PA

ABL DIAGNOSTICS (ABLD.PA) Stock Fundamental Analysis

EPA:ABLD - FR001400AHX6 - Common Stock

4.8 EUR
0 (0%)
Last: 9/3/2025, 7:00:00 PM
Fundamental Rating

3

ABLD gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 13 industry peers in the Trading Companies & Distributors industry. While ABLD seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, ABLD is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

ABLD had positive earnings in the past year.
In the past year ABLD had a positive cash flow from operations.
ABLD had positive earnings in 4 of the past 5 years.
ABLD had negative operating cash flow in 4 of the past 5 years.
ABLD.PA Yearly Net Income VS EBIT VS OCF VS FCFABLD.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M

1.2 Ratios

The Return On Assets of ABLD (1.36%) is worse than 61.54% of its industry peers.
With a Return On Equity value of 2.70%, ABLD is not doing good in the industry: 61.54% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA 1.36%
ROE 2.7%
ROIC N/A
ROA(3y)3.32%
ROA(5y)3.14%
ROE(3y)6.99%
ROE(5y)5.41%
ROIC(3y)N/A
ROIC(5y)N/A
ABLD.PA Yearly ROA, ROE, ROICABLD.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

Looking at the Profit Margin, with a value of 3.13%, ABLD is in the better half of the industry, outperforming 69.23% of the companies in the same industry.
ABLD does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 3.13%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ABLD.PA Yearly Profit, Operating, Gross MarginsABLD.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300 400

5

2. Health

2.1 Basic Checks

ABLD does not have a ROIC to compare to the WACC, probably because it is not profitable.
ABLD has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, ABLD has more shares outstanding
The debt/assets ratio for ABLD has been reduced compared to a year ago.
ABLD.PA Yearly Shares OutstandingABLD.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ABLD.PA Yearly Total Debt VS Total AssetsABLD.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

An Altman-Z score of 7.85 indicates that ABLD is not in any danger for bankruptcy at the moment.
ABLD has a better Altman-Z score (7.85) than 100.00% of its industry peers.
ABLD has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.26, ABLD is doing good in the industry, outperforming 69.23% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z 7.85
ROIC/WACCN/A
WACC7.72%
ABLD.PA Yearly LT Debt VS Equity VS FCFABLD.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M

2.3 Liquidity

ABLD has a Current Ratio of 2.06. This indicates that ABLD is financially healthy and has no problem in meeting its short term obligations.
ABLD has a Current ratio (2.06) which is in line with its industry peers.
A Quick Ratio of 1.92 indicates that ABLD should not have too much problems paying its short term obligations.
ABLD has a better Quick ratio (1.92) than 84.62% of its industry peers.
Industry RankSector Rank
Current Ratio 2.06
Quick Ratio 1.92
ABLD.PA Yearly Current Assets VS Current LiabilitesABLD.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 420.59% over the past year.
Measured over the past years, ABLD shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -48.36% on average per year.
ABLD shows a decrease in Revenue. In the last year, the revenue decreased by -5.03%.
EPS 1Y (TTM)420.59%
EPS 3Y-48.36%
EPS 5YN/A
EPS Q2Q%134.78%
Revenue 1Y (TTM)-5.03%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-18.02%

3.2 Future

Based on estimates for the next years, ABLD will show a very strong growth in Earnings Per Share. The EPS will grow by 41.42% on average per year.
Based on estimates for the next years, ABLD will show a very strong growth in Revenue. The Revenue will grow by 41.75% on average per year.
EPS Next Y100%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year34.37%
Revenue Next 2Y41.75%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ABLD.PA Yearly Revenue VS EstimatesABLD.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2022 2023 2024 2025 2026 2M 4M 6M 8M 10M
ABLD.PA Yearly EPS VS EstimatesABLD.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 0.02 0.04 0.06

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 240.00, ABLD can be considered very expensive at the moment.
76.92% of the companies in the same industry are cheaper than ABLD, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.84, ABLD is valued quite expensively.
Based on the Price/Forward Earnings ratio of 78.43, the valuation of ABLD can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ABLD indicates a slightly more expensive valuation: ABLD is more expensive than 69.23% of the companies listed in the same industry.
ABLD's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.48.
Industry RankSector Rank
PE 240
Fwd PE 78.43
ABLD.PA Price Earnings VS Forward Price EarningsABLD.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ABLD.PA Per share dataABLD.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3 0.4

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ABLD does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as ABLD's earnings are expected to grow with 41.42% in the coming years.
PEG (NY)2.4
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3YN/A

1

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.11%, ABLD has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.79, ABLD is paying slightly less dividend.
With a Dividend Yield of 1.11, ABLD pays less dividend than the S&P500 average, which is at 2.32.
Industry RankSector Rank
Dividend Yield 1.11%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ABLD.PA Yearly Dividends per shareABLD.PA Yearly Dividends per shareYearly Dividends per share 2025 0.01 0.02 0.03 0.04

5.3 Sustainability

DPN/A
EPS Next 2Y41.42%
EPS Next 3YN/A
ABLD.PA Yearly Income VS Free CF VS DividendABLD.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M

ABL DIAGNOSTICS

EPA:ABLD (9/3/2025, 7:00:00 PM)

4.8

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners99.64%
Ins Owner ChangeN/A
Market Cap77.33M
Analysts85.71
Price Target6.28 (30.83%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.11%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 240
Fwd PE 78.43
P/S 13.1
P/FCF N/A
P/OCF 97.32
P/B 11.29
P/tB 18.4
EV/EBITDA N/A
EPS(TTM)0.02
EY0.42%
EPS(NY)0.06
Fwd EY1.28%
FCF(TTM)0
FCFYN/A
OCF(TTM)0.05
OCFY1.03%
SpS0.37
BVpS0.43
TBVpS0.26
PEG (NY)2.4
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.36%
ROE 2.7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 3.13%
GM N/A
FCFM N/A
ROA(3y)3.32%
ROA(5y)3.14%
ROE(3y)6.99%
ROE(5y)5.41%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 13.8%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.06
Quick Ratio 1.92
Altman-Z 7.85
F-Score5
WACC7.72%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)420.59%
EPS 3Y-48.36%
EPS 5YN/A
EPS Q2Q%134.78%
EPS Next Y100%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.03%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-18.02%
Revenue Next Year34.37%
Revenue Next 2Y41.75%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-76.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year789.36%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y98.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y61.93%
OCF growth 3YN/A
OCF growth 5YN/A